OPRX - OptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call Transcript

OptimizeRx Corporation. (OPRX) Q4 2021 Earnings Conference Call February 24, 2022, 04:30 PM ET Company Participants William Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial Officer Stephen Silvestro - Chief Commercial Officer Andrew D’Silva - Senior Vice President of Corporate Finance Conference Call Participants Ryan Daniels - William Blair Sean Dodge - RBC Capital Markets Marc Wiesenberger - B. Riley Securities Eric Martinuzzi - Lake Street Harvey Poppel - Poptech Capital LLP Presentation Operator Good afternoon and thank you for joining OptimizeRx Fourth Quarter Fiscal 2021 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Company Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Stephen Silvestro; Executive Vice President of Finance and Accounting, Doug Baker; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva. At the conclusion of today’s earnings call,

For further details see:

OptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call Transcript